CLASS II Drug recall · Reported 10 Sep 2014 · FDA Enforcement Report
Paxil CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg recalled
Apotex is recalling Paxil CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, distributed nationwide in the US. The recall was initiated on 24 Mar 2014 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1579-2014
- FDA event ID
- 68967
- Recalling firm
- Apotex, Toronto
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 24 Mar 2014
- FDA classified
- 3 Sep 2014
- Reported
- 10 Sep 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Antidepressants
Timeline
| 24 Mar 2014 | Recall initiated by company | |
| 3 Sep 2014 | Classified by FDA | +163 days |
| 10 Sep 2014 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Product as listed by the FDA
PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 37.5 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3670-3
Where it was distributed
Nationwide and Puerto Rico
Questions about this recall
Why was it recalled?
Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.
Which lots are affected?
Lot # 2E001; Exp. 05/15
Where was it sold?
Nationwide and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 27 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
8 other products · FDA event 68967This product is part of a recall event; the main page for the event is Paroxetine HCL Controlled-Release Tablets 25 mg recalled by Apotex.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Paroxetine HCL Controlled-Release Tablets 25 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paxil (Paroxetine HCL) Tablets 40 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paxil (Paroxetine HCL) Tablets 10 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paroxetine HCL Controlled-Release Tablets 37.5 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paxil CR (Paroxetine HCL) Controlled-Release Tablets 25 mg recalled | Apotex | Other | Nationwide | |
| CLASS II | Paxil (Paroxetine HCL) Oral Suspension 10 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paxil (Paroxetine HCL) Tablets 20 mg recalled by Apotex | Apotex | Other | Nationwide | |
| CLASS II | Paroxetine HCL Controlled-Release Tablets 12.5 mg recalled by Apotex | Apotex | Other | Nationwide |
More recalls from Apotex
All 75| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalled | Apotex | Potency & Assay | Nationwide |
| Drug | CLASS II | Desmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalled | Apotex | Other | Nationwide |
| Drug | CLASS II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution | Apotex | Sterility | Nationwide |
| Drug | CLASS II | Ketorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac Tromethamine | Apotex | Sterility | Nationwide |
| Drug | CLASS II | Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution recalledBrimonidine Tartrate/timolol Maleate Ophthalmic Solution | Apotex | Sterility | Nationwide |
Other Paxil (paroxetine recalls
All 6| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Paxil (Paroxetine HCL) Tablets 20 mg recalled by Apotex | Apotex | Other | Nationwide |
| Drug | CLASS II | Paxil (Paroxetine HCL) Oral Suspension 10 mg recalled by Apotex | Apotex | Other | Nationwide |
| Drug | CLASS II | Paxil CR (Paroxetine HCL) Controlled-Release Tablets 25 mg recalled | Apotex | Other | Nationwide |
| Drug | CLASS II | Paxil (Paroxetine HCL) Tablets 10 mg recalled by Apotex | Apotex | Other | Nationwide |
| Drug | CLASS II | Paxil (Paroxetine HCL) Tablets 40 mg recalled by Apotex | Apotex | Other | Nationwide |